MPO and inflammatory bowel disease: Patients with IBD have indicated that urinary biomarkers are preferred to fecal markers.35 A recent systematic review highlighted urinary biomarkers tested in IBD, though the focus for many of these studies was discrimination of individuals with IBD from healthy individuals.36 Here, we investigated elevated urinary GSA as an indirect measure of myeloperoxidase activity in IBD.